Last updated on June 2019

Prostate Cancer Biomarker Enrichment and Treatment Selection


Brief description of study

The purpose of the pre-study screening is to test for DNA abnormalities or biomarkers.

Detailed Study Description

This testing will be done on a samples of blood to see whether or not patients are eligible to take part in one of the main studies. Each study will be looking at what effects a new drug or drugs has on prostate cancer and will also be looking at the side effects of treatment. The purpose of the main studies is to see if the biomarkers that were identified screening samples can help predict which patients are most likely to be helped by that drug or drugs and to see how the cancer cells respond to treatment.

Clinical Study Identifier: NCT03385655

Find a site near you

Start Over